Stuttgart - Delayed Quote • EUR Bio-Rad Laboratories Inc (BUWA.SG) Follow Add holdings 209.00 -14.20 (-6.36%) As of May 15 at 8:03:59 AM GMT+2. Market Open. Comparisons Indicators Technicals Corporate Events Draw List View Grid View Detach Attach No Tool Measure UNDO Redo All All Favorites Text Statistics Technicals Fibonacci Markings Lines Annotation Arrow Line Horizontal Vertical Rectangle Trend Line Measurement Line Average Line Callout Channel Check Continuous Crossline Elliott Wave Ellipse Doodle Fib Projection Fib Arc Fib Fan Fib Time Zone Focus Gann Fan Gartley Heart Pitchfork Quadrant Lines Ray Regression Line Fib Retracement Star Speed Resistance Arc Speed Resistance Line Time Cycle Tirone Levels Volume Profile Cross Magnet Clear All Drawings Restore Default Parameters Loading Chart for BUWA.SG 1D 5D 1M 3M 6M YTD 1Y 5Y All Date Range 1 min Recent News: BUWA.SG View More All News Press Releases SEC Filings Investing in Bio-Rad (BIO)? Don't Miss Assessing Its International Revenue Trends Bio-Rad's Management to Participate in Fireside Chat During 2025 RBC Capital Markets Global Healthcare Conference Bio-Rad Laboratories First Quarter 2025 Earnings: EPS: US$2.29 (vs US$13.46 in 1Q 2024) Analysts Have Been Trimming Their Bio-Rad Laboratories, Inc. (NYSE:BIO) Price Target After Its Latest Report Q1 2025 Bio Rad Laboratories Inc Earnings Call BIO Beats on Q1 Earnings, Lowers '25 View, Stock Up in Aftermarket Bio-Rad Laboratories Inc (BIO) Q1 2025 Earnings Call Highlights: Navigating Challenges with ... Bio-Rad: Q1 Earnings Snapshot Bio-Rad Laboratories (BIO) Q1 Earnings Surpass Estimates Bio-Rad Reports First-Quarter 2025 Financial Results Bio-Rad Laboratories, Inc. (BIO): Among Billionaire Mason Hawkins’ Small-Cap Stocks with Huge Upside Potential